Article info
PDFOriginal article
The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia–dysplasia–adenocarcinoma sequence in Barrett’s oesophagus
- Correspondence to: Dr K Koss Digestive Diseases Centre, University Department of Genetics and Molecular Medicine, Level 4, Windsor Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK; konradkossyahoo.com
Citation
The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia–dysplasia–adenocarcinoma sequence in Barrett’s oesophagus
Publication history
- Accepted June 1, 2004
- First published October 27, 2004.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Clinical Pathology